Constitutively activated stat3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting stat3 sensitizes them to iressa and alkylators.
admin | Related Articles |
Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators.
Clin person Res. 2008 Oct 1;14(19):6042-54
Authors: Lo HW, Cao X, Zhu H, Ali-Osman F
PURPOSE: The goals of this think are to explicate the relation of the oncogenic transcription bourgeois communication sensor and activator of transcription 3 (STAT3) with glioma belligerence and to see the persona of broad STAT3 state in the status of cancerous gliomas and medulloblastomas to chemotherapy. EXPERIMENTAL DESIGN: Immunohistochemical soiling and biochemical methods were utilised to investigate the extent of STAT3 activation and EGFR countenance in direct specimens and radiophone lines, respectively. Cellular salutation to take treatments was observed using radiophone cytotoxicity and clonogenic ontogeny assays. RESULTS: We institute STAT3 to be constitutively reactive in 60% of direct high-grade/malignant gliomas and the extent of activation correlated positively with glioma grade. High levels of activated/phosphorylated STAT3 were also inform in cultured manlike cancerous glioma and medulloblastoma cells. Three STAT3-activating kinases, Janus-activated kinase 2 (JAK2), EGFR, and EGFRvIII, contributed to STAT3 activation. An inhibitor to JAK2/STAT3, JSI-124, significantly low countenance of STAT3 direct genes, quelled cancer radiophone growth, and evoked apoptosis. Furthermore, we institute that STAT3 constitutive activation coexisted with EGFR countenance in 27.2% of direct high-grade/malignant gliomas and much coexpression correlated positively with glioma grade. Combination of an anti-EGFR businessperson Iressa and a JAK2/STAT3 inhibitor synergistically quelled STAT3 activation and potently killed glioblastoma radiophone lines that spoken EGFR or EGFRvIII. JSI-124 also sensitized cancerous glioma and medulloblastoma cells to temozolomide, 1,3-bis(2-chloroethyl)-1-nitrosourea, and cisplatin in which a activity existed between JSI-124 and cisplatin. CONCLUSION: STAT3 constitutive activation, lonely and in accord with EGFR expression, plays an essential persona in high-grade/malignant gliomas and targeting STAT3/JAK2 sensitizes these tumors to anti-EGFR and alkylating agents.
PMID: 18829483 [PubMed - in process]
(Source: Clinical person Research)
Tags: apoptosis, ATM, Cancer, chemotherapy, Expression, Genes, glioma, Led, Toxicity
Posted in Cancer |